Cero Therapeutics Holdings, Inc. (CERO)
Cero Therapeutics Holdings, Inc. (CERO) Insider Trading
Directors, officers and holders of more than 10% of CERO report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 60 transactions on file: 0 with code P, 7 with code S and 43 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 4, 2026 | Francois Eric | Director | A Award | 1,823,278 | Not measured | Not measured |
| Jan 7, 2026 | KUCHARCHUK ANDREW ALBERT | Chief Financial Officer | A Award | 1,162,099 | Not measured | Not measured |
| Jan 7, 2026 | Byrnes Michael | Director | A Award | 690,900 | Not measured | Not measured |
| Jan 7, 2026 | Rolfe Lindsey | Director | A Award | 690,900 | Not measured | Not measured |
| Jan 7, 2026 | LAPORTE KATHLEEN | Director | A Award | 690,900 | Not measured | Not measured |
| Jan 7, 2026 | Patel Shami | Director | A Award | 690,900 | Not measured | Not measured |
| Jan 7, 2026 | Pierce Kristen | Chief Development Officer | A Award | 1,612,099 | Not measured | Not measured |
| Jan 7, 2026 | ATWOOD BRIAN G | Director | A Award | 1,612,099 | Not measured | Not measured |
| Jan 7, 2026 | Ehrlich Christopher B | Chairman and CEO | A Award | 4,530,997 | Not measured | Not measured |
| May 30, 2025 | Rolfe Lindsey | Director | A Award | 9,326 | Not measured | Not measured |
| May 30, 2025 | KUCHARCHUK ANDREW ALBERT | Chief Financial Officer | A Award | 152,500 | Not measured | Not measured |
| May 30, 2025 | Pierce Kristen | Chief Development Officer | A Award | 154,841 | Not measured | Not measured |
| May 30, 2025 | ATWOOD BRIAN G | Director | A Award | 122,549 | Not measured | Not measured |
| May 30, 2025 | Ehrlich Christopher B | Chairman and CEO | A Award | 61,843 | Not measured | Not measured |
| May 30, 2025 | Byrnes Michael | Director | A Award | 9,326 | Not measured | Not measured |
| May 30, 2025 | Patel Shami | Director | A Award | 11,693 | Not measured | Not measured |
| May 30, 2025 | LAPORTE KATHLEEN | Director | A Award | 9,326 | Not measured | Not measured |
| Mar 31, 2025 | ATWOOD BRIAN G | Director | M Exercise | 294,460 | $0.0001 | $29 |
| Mar 31, 2025 | ATWOOD BRIAN G | Director | M Exercise | 14,723 | $0.0020 | $29 |
| Mar 4, 2025 | Ehrlich Christopher B | Chairman and CEO | A Award | 119,486 | Not measured | Not measured |
| Mar 4, 2025 | LAPORTE KATHLEEN | Director | A Award | 17,923 | Not measured | Not measured |
| Mar 4, 2025 | Patel Shami | Director | A Award | 14,936 | Not measured | Not measured |
| Mar 4, 2025 | Rolfe Lindsey | Director | A Award | 17,923 | Not measured | Not measured |
| Mar 4, 2025 | Byrnes Michael | Director | A Award | 17,923 | Not measured | Not measured |
| Mar 4, 2025 | ATWOOD BRIAN G | Director | A Award | 14,936 | Not measured | Not measured |
| Feb 24, 2025 | Rolfe Lindsey | Director | A Award | 127,500 | Not measured | Not measured |
| Feb 24, 2025 | Ehrlich Christopher B | Chairman and CEO | A Award | 1,275,000 | Not measured | Not measured |
| Feb 24, 2025 | Byrnes Michael | Director | A Award | 127,500 | Not measured | Not measured |
| Feb 24, 2025 | Patel Shami | Director | A Award | 127,500 | Not measured | Not measured |
| Feb 24, 2025 | ATWOOD BRIAN G | Director | A Award | 254,000 | Not measured | Not measured |
| Feb 24, 2025 | LAPORTE KATHLEEN | Director | A Award | 127,500 | Not measured | Not measured |
| Feb 7, 2025 | ATWOOD BRIAN G | Director | A Award | 204,080 | $0.0001 | $20 |
| Feb 7, 2025 | ATWOOD BRIAN G | Director | A Award | 204,080 | $1.96 | $399,976 |
| Feb 7, 2025 | ATWOOD BRIAN G | Director | A Award | 306,120 | $1.96 | $599,965 |
| Feb 7, 2025 | ATWOOD BRIAN G | Director | A Award | 306,120 | $0.0001 | $31 |
| Dec 13, 2024 | YK Bioventures Opportunities GP I, LLC | 10% Owner | S Sale | 1,499 | $120.00 | $179,934 |
| Dec 12, 2024 | YK Bioventures Opportunities GP I, LLC | 10% Owner | S Sale | 807 | $140.00 | $113,018 |
| Dec 11, 2024 | YK Bioventures Opportunities GP I, LLC | 10% Owner | S Sale | 672 | $160.00 | $107,504 |
| Dec 10, 2024 | YK Bioventures Opportunities GP I, LLC | 10% Owner | S Sale | 785 | $180.00 | $141,385 |
| Dec 9, 2024 | YK Bioventures Opportunities GP I, LLC | 10% Owner | S Sale | 425 | $220.00 | $93,560 |
| Dec 6, 2024 | YK Bioventures Opportunities GP I, LLC | 10% Owner | S Sale | 618 | $240.00 | $148,425 |
| Dec 2, 2024 | LAPORTE KATHLEEN | Director | A Award | 127,500 | Not measured | Not measured |
| Dec 2, 2024 | Ehrlich Christopher B | Chairman and CEO | A Award | 1,275,000 | Not measured | Not measured |
| Dec 2, 2024 | Byrnes Michael | Director | A Award | 127,500 | Not measured | Not measured |
| Dec 2, 2024 | Rolfe Lindsey | Director | A Award | 127,500 | Not measured | Not measured |
| Dec 2, 2024 | ATWOOD BRIAN G | Director | A Award | 254,000 | Not measured | Not measured |
| Dec 2, 2024 | Patel Shami | Director | A Award | 127,500 | Not measured | Not measured |
| Oct 10, 2024 | YK Bioventures Opportunities GP I, LLC | 10% Owner | S Sale | 1,625 | $200.00 | $325,000 |
| Oct 1, 2024 | KUCHARCHUK ANDREW ALBERT | Chief Financial Officer | A Award | 500,000 | Not measured | Not measured |
| Oct 1, 2024 | Pierce Kristen | Chief Development Officer | A Award | 200,000 | Not measured | Not measured |
The full Form 4 history is on the CERO company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.